DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
PR Newswire —
Five poster presentations span lung cancer early detection, immunotherapy response prediction, cancer subtyping, treatment monitoring, and next-generation sequencing platforms PALO ALTO, Calif., April 6, 2026 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of innovative blood-based...